The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07)

[1]  L. Strobbe,et al.  Meta‐analysis of ultrasound‐guided biopsy of suspicious axillary lymph nodes in the selection of patients with extensive axillary tumour burden in breast cancer , 2015, The British journal of surgery.

[2]  Mechthild Krause,et al.  ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  E. Rutgers,et al.  Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  V. Tjan-Heijnen,et al.  Inconsistent selection and definition of local and regional endpoints in breast cancer research , 2014, The British journal of surgery.

[5]  M. Piccart,et al.  Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer research. , 2014, Journal of the National Cancer Institute.

[6]  R. Mansel,et al.  Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. , 2014, The Lancet. Oncology.

[7]  R. Beets-Tan,et al.  Axillary ultrasound for preoperative nodal staging in breast cancer patients: is it of added value? , 2013, Breast.

[8]  S. Goyal,et al.  Incidental radiation to axilla in early breast cancer treated with intensity modulated tangents and comparison with conventional and 3D conformal tangents. , 2013, Breast.

[9]  R. Bosc,et al.  The standard tangential fields used for breast irradiation do not allow optimal coverage and dose distribution in axillary levels I-II and the sentinel node area. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  B. Newman,et al.  Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. , 2013, The Lancet. Oncology.

[11]  A. Luini,et al.  Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. , 2013, The Lancet. Oncology.

[12]  S. Rodenhuis,et al.  Early Assessment of Axillary Response with 18F-FDG PET/CT during Neoadjuvant Chemotherapy in Stage II–III Breast Cancer: Implications for Surgical Management of the Axilla , 2013, Annals of Surgical Oncology.

[13]  W. Mali,et al.  Value of Preoperative Ultrasound-Guided Axillary Lymph Node Biopsy for Preventing Completion Axillary Lymph Node Dissection in Breast Cancer: A Systematic Review and Meta-Analysis , 2013, Annals of Surgical Oncology.

[14]  M. Silverstein,et al.  Accuracy of Predicting Axillary Lymph Node Positivity by Physical Examination, Mammography, Ultrasonography, and Magnetic Resonance Imaging , 2012, Annals of Surgical Oncology.

[15]  S. Ciatto,et al.  Preoperative Ultrasound-Guided Needle Biopsy of Axillary Nodes in Invasive Breast Cancer: Meta-Analysis of Its Accuracy and Utility in Staging the Axilla , 2011, Annals of surgery.

[16]  M. Christiaens,et al.  Lymphoedema Functioning, Disability and Health Questionnaire (Lymph-ICF): Reliability and Validity , 2011, Physical Therapy.

[17]  L. Strobbe,et al.  Systematic review of the effect of external beam radiation therapy to the breast on axillary recurrence after negative sentinel lymph node biopsy , 2011, The British journal of surgery.

[18]  A. Giuliano,et al.  Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. , 2011, JAMA.

[19]  P. Iyengar,et al.  Can preoperative axillary US help exclude N2 and N3 metastatic breast cancer , 2011 .

[20]  T. Julian,et al.  Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. , 2010, The Lancet. Oncology.

[21]  Kelly K. Hunt,et al.  Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. , 2010, Annals of surgery.

[22]  Hiroyuki Abe,et al.  Axillary lymph nodes suspicious for breast cancer metastasis: sampling with US-guided 14-gauge core-needle biopsy--clinical experience in 100 patients. , 2009, Radiology.

[23]  B. Cady,et al.  Axillary lymph nodes: US-guided fine-needle aspiration for initial staging of breast cancer--correlation with primary tumor size. , 2008, Radiology.

[24]  J. Vries,et al.  Personality Predicts Quality of Life Six Months after the Diagnosis and Treatment of Breast Disease , 2007, Annals of Surgical Oncology.

[25]  M. Hočevar,et al.  Patients with preoperatively ultrasonically uninvolved axillary lymph nodes: a distinct subgroup of early breast cancer patients , 2006, Breast Cancer Research and Treatment.

[26]  E. Steegers,et al.  Validation of the Dutch Short Form of the State Scale of the Spielberger State-Trait Anxiety Inventory: Considerations for Usage in Screening Outcomes , 2003, Public Health Genomics.

[27]  F. Peintinger,et al.  Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients , 2003, British Journal of Cancer.

[28]  Jong-Hyeon Jeong,et al.  Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. , 2002, The New England journal of medicine.

[29]  A. Vincent-Salomon,et al.  Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  B. Turnbull,et al.  Group Sequential Methods with Applications to Clinical Trials , 1999 .

[31]  N. Aaronson,et al.  The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[33]  M. Pamilo,et al.  Real‐time ultrasound, axillary mammography, and clinical examination in the detection of axillary lymph node metastases in breast cancer patients. , 1989, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.